| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 7.23B | 7.42B | 7.02B | 6.10B | 5.23B | 4.36B |
| Gross Profit | 3.92B | 5.02B | 4.10B | 3.61B | 4.23B | 2.25B |
| EBITDA | 3.46B | 3.51B | 3.42B | 2.98B | 2.57B | 2.07B |
| Net Income | 1.99B | 2.00B | 1.95B | 1.72B | 1.49B | 1.21B |
Balance Sheet | ||||||
| Total Assets | 294.27B | 297.18B | 222.40B | 237.73B | 269.11B | 222.92B |
| Cash, Cash Equivalents and Short-Term Investments | 216.52B | 19.33B | 130.41B | 140.50B | 138.23B | 110.97B |
| Total Debt | 0.00 | 8.14B | 9.58B | 8.72B | 5.36B | 6.32B |
| Total Liabilities | 283.25B | 285.56B | 210.85B | 227.63B | 260.05B | 215.18B |
| Stockholders Equity | 10.56B | 11.31B | 10.77B | 9.66B | 8.47B | 7.19B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 2.75B | 2.05B | 2.28B | 2.16B | 702.50M |
| Operating Cash Flow | 0.00 | 2.81B | 2.41B | 2.55B | 2.48B | 908.90M |
| Investing Cash Flow | 0.00 | 22.00M | -60.00M | -4.00B | -1.41B | -2.17B |
| Financing Cash Flow | 0.00 | -1.89B | -1.35B | 2.29B | -951.10M | 798.70M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
79 Outperform | €45.71B | 20.53 | 18.67% | 1.79% | 9.07% | 10.34% | |
60 Neutral | €450.17M | 14.91 | 12.64% | 2.65% | 3.28% | -26.16% | |
57 Neutral | €38.46B | 15.51 | 7.86% | 1.82% | -2.40% | 19.42% | |
56 Neutral | €512.30M | 33.18 | 7.03% | ― | 61.87% | -32.87% | |
55 Neutral | $6.65B | 3.83 | -15.92% | 6.20% | 10.91% | 7.18% | |
42 Neutral | €422.52M | -2.00 | -10.36% | 3.61% | -14.47% | -542.84% |